DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 69.70.
| Share Price | ₹6,523.3 | Nov 17,2025 |
| Market Cap | ₹173,192.3 Cr | |
| Earnings-TTM | ₹2,485.0 Cr | TTM-Consolidated Results |
| Price/Earnings | 69.70x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹173,192.3 Cr] as on Nov 17,2025
(/) Earnings [ ₹2,485.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 69.70x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 69.70 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 51.17x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 48.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 69.83x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 39.49x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| DIVIS LABORATORIES | 2,485.00 | 69.70 | 173,192.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 40.23 | 423,171.0 |
| CIPLA LTD | 5,453.86 | 22.75 | 124,094.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.36 | 129,176.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.15 | 103,869.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.44 | 92,658.1 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.90 | 94,012.4 |
| LUPIN LTD | 4,347.53 | 21.56 | 93,713.9 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.84 | 71,856.8 |
| ABBOTT INDIA LTD | 1,508.95 | 41.69 | 62,904.6 |
| ALKEM LABORATORIES LTD | 2,411.72 | 28.37 | 68,427.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.15x |
| Max industry PE | 69.70x |
| Median industry PE | 28.37x |
| Average industry PE | 35.91x |
You may also like the below Video Courses